Renin–angiotensin–aldosterone system inhibitors and COVID-19
Kieran L. Quinn, Michael Fralick, Jonathan S. Zipursky, Nathan M. Stall
Abstract
KEY POINTS Emerging data suggest that people with hypertension or diabetes who are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and diagnosed with coronavirus disease 2019 (COVID-19) are at an increased risk of respiratory failure and death. These patients are often
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineDiabetes mellitusRenin–angiotensin systemSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Aldosterone2019-20 coronavirus outbreakCoronavirusInternal medicineDiseaseEndocrinologyVirologyBlood pressureInfectious disease (medical specialty)OutbreakCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19COVID-19 and Mental Health